Recent publications on Cancer

Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ; for the Pharmacovigilance Research Group. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May;52(5):e30-8. doi: 10.1097/MLR.0b013e31825a8c22. Epub 2012 May 25. PubMed

Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.  Ann Epidemiol. 2012 May;22(5):340-8. Epub 2012 Feb 25. PubMed

Pocobelli G, Chubak J, Hanson N, Drescher C, Resta R, Urban N, Buist DS. Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling. Gynecol Oncol. 2012 Aug;126(2):229-35. Epub 2012 May 4. PubMed

Mazor KM, Roblin DW, Greene SM, Lemay CA, Firneno CL, Calvi J, Prouty CD, Horner K, Gallagher TH. Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response.  J Clin Oncol. 2012 May 20;30(15):1784-90. Epub 2012 Apr 16. PubMed

Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huan H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156(9):609-17. PubMed

Lowry SJ, Loggers ET, Bowles EJ, Wagner EH. Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.  Am J Manag Care. 2012;18(5 Spec No. 2):SP77-83. PubMed

Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012 May;156(9):635-48. PubMed

Lowry SJ, Loggers ET, Bowles EJ, Wagner EH. Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for comparative effectiveness research. J Oncol Pract. 2012 May;8(3 Suppl):28s-33s. PubMed

Bowles EJ, Feigelson HS, Barney T, Broecker K, Sterrett A, Bischoff K, Engel J, Gundersen G, Sheehey-Jones J, Single R, Onitilo A, James TA, McCahill LE. Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database.  BMC Cancer. 2012 Apr 3;12(1):136 PubMed

Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL. Association between time spent interpreting, level of confidence, and accuracy of screening mammography.  AJR Am J Roentgenol. 2012;198(4):970-8. PubMed

Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.  Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15. PubMed

Mahajan K, Coppola D, Chen YA, Zhu W, Lawrence HR, Lawrence NJ, Mahajan NP. Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. Am J Pathol. 2012 Apr;180(4):1386-93. doi: 10.1016/j.ajpath.2011.12.028. Epub 2012 Feb 7. PubMed

Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, O'Keeffe Rossetti MC, Elston Lafata J. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15;118(22):5644-51. doi: 10.1002/cncr.27544. Epub 2012 Mar 20. PubMed

Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women.  Med Care. 2012 Mar;50(3):210-6. PubMed

Aiello Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 through 2008 varies by age of breast cancer diagnosis and tumor size. J Oncol Pract. 2012;8(2):113-20. PubMed

Jackson SL, Cook AJ, Miglioretti DL, Carney PA, Geller BM, Onega T, Rosenberg RD, Brenner RJ, Elmore JG. Are radiologists' goals for mammography accuracy consistent with published recommendations?  Acad Radiol. 2012 Mar;19(3):289-95. Epub 2011 Nov 30. PubMed

Delate T, Witt DM, Ritzwoller D, Weeks JC, Kushi L, Hornbrook MC, Aiello Bowles EJ, Schrag D. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012;17(3):419-27. doi: 10.1634/theoncologist.2011-0323. Epub 2012 Feb 14. PubMed

Trentham-Dietz A, Sprague BL, Wang J, Hampton JM, Buist DS, Aiello Bowles E, Sisney G, Burnside E, Hemming J, Hedman C. Phenol xenoestrogens and mammographic breast density.  Cancer Epidemiol Biomarkers Prev. 2012;21(3):561-2. Epub 2012 Feb 15. PubMed

Braithwaite D, Zhu W, Hubbard R, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Wernli K, Moore D, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Benefits and harms of screening mammography frequency by age and comorbidity score.  Cancer Epidemiol Biomarkers Prev. 2012;21(3):565. Epub 2012 Feb 15. PubMed

Beaber E, Buist D, Barlow W, Malone K, Reed S, Li C. Relationship between use of different oral contraceptive formulations and breast cancer risk among young women.  Cancer Epidemiol Biomarkers Prev. 2012;21(3):566. Epub 2012 Feb 15. PubMed